|?|| (A;A) (A;G) (G;G) ||28|
The effectiveness of 17 alpha-hydroxyprogesterone caproate
for prevention of recurrent preterm birth is influenced by SNPs.
- rs471767 homozygous for the major allele treatment significantly reduced the rate of preterm birth.
- rs578029 who had a least one copy of the major allele, treatment significantly reduced in preterm birth
- a least one copy of the minor allele of rs503362 had a significant reduction with treatment
- with at least one copy of the minor allele of rs666553 had a significant reduction in very preterm birth
[PMID 19382201] Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population
[PMID 21148628] Progesterone receptor gene variants and risk of endometrial cancer
[PMID 21600550] Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate
[PMID 20308837] Progesterone receptor genotype, family history, and spontaneous preterm birth.